Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Structural Interventional Cardiology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1660381

Conditional One-Year Outcomes after Emergent Conversion to Open Heart Surgery during Transcatheter Aortic Valve Implantation. A Propensity-Matched Landmark Analysis

Provisionally accepted
Giuseppe  NassoGiuseppe Nasso1*Walter  VignaroliWalter Vignaroli1Gaetano  ContegiacomoGaetano Contegiacomo1Alfredo  MarcheseAlfredo Marchese1Ernesto  GrecoErnesto Greco2Khalil  FattouchKhalil Fattouch1Raffaele  BonifaziRaffaele Bonifazi1Flavio  FioreFlavio Fiore1Giacomo  SchincoGiacomo Schinco1Antongiulio  ValenzanoAntongiulio Valenzano1Carlo  SolimandoCarlo Solimando1Vito  MargariVito Margari1Fabrizio  RestaFabrizio Resta1Tommaso  LoizzoTommaso Loizzo1Dritan  HilaDritan Hila1Domenico  PaparellaDomenico Paparella3Giuseppe  SpezialeGiuseppe Speziale1
  • 1Gruppo Villa Maria SpA, Lugo, Italy
  • 2Universita Europea di Roma, Rome, Italy
  • 3Universita degli Studi di Foggia, Foggia, Italy

The final, formatted version of the article will be published soon.

Emergent conversion to open-heart surgery (E-OHS) during transcatheter aortic valve implantation (TAVI) is rare (0.5-2%) but carries high peri-operative mortality. Long-term outcomes in survivors beyond 30 days are not well defined.To assess 1-year conditional outcomes in patients who survived ≥30 days post-TAVI, comparing E-OHS survivors with propensity-matched uncomplicated TAVI recipients.Methods: From January 2020 to August 2023, 825 consecutive TAVI procedures were performed at three Italian centers; 11 patients (1.3%) required E-OHS for catastrophic intraprocedural complications. A 30-day landmark analysis excluded early deaths (E-OHS: n = 3; controls: n = 25). Propensity matching (1:10) was performed on nine variables, yielding 8 E-OHS survivors and 80 well-matched controls.All-cause mortality from day 31 to 1 year. Secondary endpoints: Composite of death, moderate-or-greater paravalvular regurgitation, or valve re-intervention; heart failure rehospitalization; permanent pacemaker; stroke/TIA; and acute kidney injury (AKI).Results: Baseline characteristics were comparable. Mean age was 77 ± 5 years; EuroSCORE II was 6.8 ± 2.1%. One-year conditional mortality was 0% in E-OHS vs 2.9% in controls (p = 0.64). The composite endpoint occurred in 12.5% vs 13.6% (p = 0.88). Other outcomes were similar: heart failure rehospitalization (12.5% vs 11.2%), pacemaker implantation (12.5% vs 9.6%), stroke/TIA (0% vs 1.2%), AKI (0% vs 7.2%). No structural valve deterioration or thrombosis was observed.Conclusions: E-OHS survivors who overcome the initial high risk phase achieve 1-year outcomes comparable to standard TAVI patients. These findings support immediate surgical backup within TAVI programs and provide reassurance for high-risk patient counselling.

Keywords: TAVI, surgical bailout, surgical stand-by, aortica valve replacement, TAVR

Received: 05 Jul 2025; Accepted: 27 Aug 2025.

Copyright: © 2025 Nasso, Vignaroli, Contegiacomo, Marchese, Greco, Fattouch, Bonifazi, Fiore, Schinco, Valenzano, Solimando, Margari, Resta, Loizzo, Hila, Paparella and Speziale. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Giuseppe Nasso, Gruppo Villa Maria SpA, Lugo, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.